Skip links

A Surgical Revolution: The Case for Single-Use Sterility

The Hidden Threat of Surgical Site Infections

In the realm of surgery, a hidden adversary persists, one that lurks unseen yet impacts millions: Surgical Site Infections (SSIs). These infections are a leading cause of post-operative complications– extending hospital stays, increasing readmission rates, and inflating healthcare costs dramatically. Despite advancements in medical practices, SSIs continue to plague the healthcare industry, representing a critical challenge that demands attention and action.

The Centers for Disease Control and Prevention (CDC) defines SSIs as infections related to an operative procedure that occur at or near the surgical incision within 30 days of the procedure, or within 90 days if prosthetic material is implanted. These infections can range from superficial incisions to life-threatening conditions and are classified based on the depth and severity of the infection.

A Deep Dive into Sterilization Failures

Sterilization of surgical instruments is the bedrock of preventing SSIs, yet the reality of this practice is alarmingly inconsistent. The Joint Commission’s findings are a testament to this inconsistency, as over half of all inspected hospitals and ambulatory surgery centers failed to meet the required standards for instrument sterilization.1 This failure is not a mere oversight but a significant contributor to the rise in SSIs, particularly those resistant to multiple antibiotics. The cost of these infections is not just measured in patient suffering but also in the tangible economic burden on the healthcare system.

The Flawed Reality of Reusable Instruments

At the heart of the sterilization issue lies a fundamental flaw: the very design of reusable surgical instruments. These instruments, with their complex structures and hard-to-reach crevices, are often challenging to clean thoroughly. The University of Michigan Medical Center’s research highlighted that even after meticulous cleaning, 98% of reusable instruments retained biological debris.2 This alarming statistic raises questions about the efficacy of current cleaning protocols and the potential need for a redesign of surgical tools with sterility as a primary concern.

The Human Factor: Sterile Processing Departments

The role of the Sterile Processing Department (SPD) is pivotal in the fight against SSIs. However, the staff often face less-than-ideal working conditions, with salaries and training that do not reflect the critical nature of their work.3 The high turnover rate and the stress associated with the job can lead to lapses in sterilization processes, increasing the risk of SSIs. This cycle of inadequate sterilization and high staff turnover is a systemic issue that requires urgent attention and remediation.

Economic and Health Impact of SSIs

The costs associated with SSIs are staggering, with the U.S. healthcare system spending over $3.3 billion annually on these infections.4 For hospitals, the implications are twofold: they bear the direct costs of extended patient care and face the indirect costs associated with lost productivity, additional treatments, and potential litigation. For patients, the impact is even more profound, with SSIs leading to longer hospital stays, additional surgeries, and in some cases, long-term health complications or death.

The SURE Retractor: Pioneering Sterility in Surgery

SURE Retractors Inc. introduces a groundbreaking solution to this pervasive issue: the world’s first single-use, sterile, pre-packaged (SSP) surgical retractor. This innovation promises to significantly reduce the risk of SSIs by ensuring that every surgical retractor is sterile at the point of use. The adoption of the SURE Retractor represents a paradigm shift from the traditional reliance on reusable instruments, offering a new standard of care that prioritizes patient safety and surgical efficiency.

Advantages of Single-Use, Sterile, Pre-Packaged Instruments

The transition to SSP instruments like the SURE Retractor is underpinned by a robust body of evidence. These instruments have been shown to reduce the rate of SSIs significantly, improving patient outcomes and reducing healthcare costs. Additionally, the use of SSP instruments aligns with economic incentives for healthcare facilities, reducing operating costs and enhancing efficiency.5

Embracing the SSP Revolution for Patient Safety

The introduction of the SURE Retractor and similar SSP technologies is not just an innovation—it is a call to action for healthcare providers to embrace a safer and more efficient future in surgical care. As the medical community grapples with the complexities of SSIs, it is imperative to adopt such innovations that promise to safeguard patient health while ensuring economic sustainability.

Looking Ahead

The fight against SSIs is a multifaceted endeavor that demands a concerted effort from all stakeholders in the healthcare sector. By adopting SSP technologies like the SURE Retractor, facilities can take a significant step toward ensuring patient safety and operational efficiency. The SURE Retractor stands as a symbol of innovation and commitment to progress, signaling a new era in the fight against the unseen peril of SSIs.



  1. Pellegrini, C. A. (2017, August 1). Improper sterilization and high-level disinfection of equipment challenges organizations. The Bulletin of the American College of Surgeons.
  2. Eaton, J. (2022, January 28). Filthy Surgical Instruments: The hidden threat in America’s Operating Rooms. Center for Public Integrity.
  3. Bouffard, K., & Kurth, J. (2016, October 28). Dirty, missing instruments plague DMC surgeries. The Detroit News.
  4. Surgical site infection – centers for disease control and prevention. (n.d.).
  5. A systematic review and cost effectiveness analysis of reusable vs. single-use flexible bronchoscopes. Anesthesia, Volume 75, Issue 4, p. 529-540. https://associationofanaesthetists-publications.onlineli-

Get the Latest

Sign up to receive the latest news.